Dernières nouvelles pour Terumo (OTC:TRUMY) Stock

Terumo

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo Corp

Terumo Corporation 2023 Q3 - Results - Earnings Call Presentation

Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript

A rating of 82 puts Terumo ADR (TRUMY) near the top of the Medical Instruments and Supplies industry according to InvestorsObserver. Terumo ADR's score of 82 means it scores higher than 82% of stocks in the industry. Terumo ADR also received an overall rating of 58, putting it above 58% of all stocks. Medical Instruments a

Where Does Terumo ADR (TRUMY) Stock Fall in the Medical Instruments & Supplies Field After It Has Risen 7.37% This Week?

Terumo Corporation reports FY GAAP EPS of ¥71.47

Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

Data-Driven Growth Fuels More Upside For Overlooked Artivion

Terumo Gaining Share In Growth Markets, But Consistency Still A Question

Terumo Corporation (TRUMF) Q1 2025 Earnings Call Transcript

ClearBridge International Growth EAFE Strategy Q3 2024 Commentary

AAGIY

AAIGF

AORT

ARGNF

ARGX

ASCCF

ASCCY

ASML

ASMLF

CFCV

CMSQF

CMSQY

CMXHF

CSLLY

DAIUF

DANOY

DFKCY

GPDNF

HLNCF

INFR

LDNXF

LGRDY

LGRVF

LNSTY

LNVGF

LNVGY

LRGE

NONOF

NSRGF

NSRGY

PUGBY

PUIGF

RKLIF

SSDOF

SSDOY

TKOMF

TKOMY

TOELF

TOELY

TRUMF

TRUMY

YLDE

Press Releases

Terumo Medical Corporation's New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System

Terumo Establishes Corporate Venture Capital "Terumo Ventures"

TYO:4543

Comments

Terumo

Actualités

Dernières nouvelles pour Terumo (OTC:TRUMY) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL